Three decades of messenger RNA vaccine development

2019/08/23 by Rein Verbeke, Ine Lentacker, Stefaan C. De Smedt +1 · 3 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · #Immune Response and Inflammation #Immunotherapy and Immune Responses #RNA Interference and Gene Delivery

paper · pdf · doi:10.1016/j.nantod.2019.100766

openalex publication_date 2019/08/23 · crossref created 2019/08/23 · crossref issued 2019/10/01 · crossref published 2019/10/01 · crossref published-print 2019/10/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/28 · openalex updated_date 2026/07/31 · crossref indexed 2026/08/01

Citations

• mRNA-based therapeutics — developing a new class of drugs
• Self-replicating Semliki Forest virus RNA as recombinant vaccine
• CD8 T‐cell priming upon mRNA vaccination is restricted to bone‐marrow‐derived antigen‐presenting cells and may involve antigen transfer from myocytes
• mRNA vaccines — a new era in vaccinology

Cited by

• mRNA therapeutics beyond vaccines: dosing precision challenges and clinical translation framework
• COVID-19 vaccine [wikipedia]
• Genetic vaccine [wikipedia]